SCHEDULE 13D/A
Beneficial Ownership Report
Starling Oncology, Inc. Filed Acc 0001213900-25-085013
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| M33 Growth I LP | 9,290,838 | 9.79% |
| M33 Growth I GP LLC | 9,290,838 | 9.79% |
| TOI M, LLC | 590,892 | 0.63% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Stake history · largest stake in each 13D and 13G
- 2026-11-13 SCHEDULE 13G/A · Chernett Jorey 5.6%
- 2026-05-15 SCHEDULE 13D/A · M33 Growth I L.P. 4.94%
- 2026-03-16 SCHEDULE 13G/A · Chernett Jorey 10.2%
- 2026-01-15 SCHEDULE 13G · Chernett Jorey 5.2%
- 2025-11-20 SCHEDULE 13D/A · M33 Growth I LP 5.46%
- 2025-09-05 SCHEDULE 13D/A · M33 Growth I LP 9.79%
- 2025-06-24 SCHEDULE 13G/A · FOG Ventures Investments, LLC 0%
- 2025-04-23 SCHEDULE 13D/A · Ravi Sarin 4.7%
- 2025-03-28 SCHEDULE 13D/A · M33 Growth I LP 19.99%
- 2024-12-06 SCHEDULE 13G/A · FMR LLC 0.0%
Loading xslSCHEDULE_13D_X01/primary_doc.xml…